U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924463) titled 'Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry' on April 04.
Brief Summary: This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.
Study Start Date: March 13
Study Type: OBSERVATIONAL
Condition:
Rhabdomyosarcoma
Intervention:
OTHER: None AHT
This study does not involve any interventions. It analyz...